[1]Choi Y, Park KJ, Ryu S, et al. Papillary thyroid carcinoma involving cervical neck lymph nodes: correlations with lymphangiogenesis and ultrasound features[J]. Endocr J,2012,59(10):941-948.
[2]Mezzanzanica D, Fabbi M, Bagnoli M, et al. Subcellular localization of activated leukocyte cell adhesion molecule is a moleculat predictor of survival in ovarian carcinoma patients[J].Clin Cancer Res,2008,14(6): 1726-1733.
[3]Shi ZhL,Zhang X.E-cadherin adhesion system and its relationship with invasion and metastasis of tumor[J].Tianjin Medical Journal,2008,36(6): 476-478. (in Chinese)
石珍亮, 张逊.E-cadherin 黏附系统及其与肿瘤侵袭转移的关系[J].天津医药,2008,36(6):476-478.
[4]Miccichè F, Da Riva L, Fabbi M, et al. Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors[J].PLoS One,2011,6 (2):e17141.
[5]Liu Ch,Tao XF,Gao ZhN,et al. Moesin and E-cadherin and the correlation and the correlation of thyroid papillary carcinoma[J]. Cancer Research on Prevention and Treatment,2012,39(1):44-47. (in Chinese)
刘畅,陶晓峰,高政南, 等. Moesin和E-cadherin与甲状腺乳头状癌侵袭的相关性[J]. 肿瘤防治研究,2012,39(1):44-47.
[6]Castellone MD, De Falco V, Rao DM.et al. The betacatenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation[J]. Cancer Res,2009,69(5):1867-1876.
[7]Maruyama K, Ochiai A, Akimoto S, et al. Cytoplasmic betacatenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer[J]. Oncology, 2000,59(4):302-309.
[8]Weichert W, Knosel T, Bellach J, et al. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival[J]. J Clin Pathol, 2004, 57(11):1160-1164.
[9]Sun LCh,Li ZhF,Li Ch, et al.AlCAM expression in esophageal cancer and its functions[J]. China Cancer,2011,20(6):447-452. (in Chinese)
孙力超,李智峰,李闯,等.ALCAM 在食管癌中的表达及其功能研究[J].中国肿瘤,2011, 20(6):447-452.
[10]Nelissen JM, Peters IM, de Grooth BG, et al. Dynamic regulation of activated leukocyte cell adhesion moleculemediated homotypic cell adhesion through the actin cytoskeleton[J].Mol Biol Cell,2000, 11(6):2057-2068.
[11]Liu L,Wu ZhH,Zhang ZL,et al.ARHⅠand E-cadherin in the expression and significance of papillary thyroid cancer[J].China Cancer,2014,23(4):333-337. (in Chinese)
刘雷,吴志宏,章载良,等. ARHⅠ和 E 钙黏蛋白在乳头状甲状腺癌中的表达及意义[J].中国肿瘤,2014,23(4):333-337.
[12]Suriano G, Oliveira MJ, Hunt sman D, et al. E-cadherin germline missense mutations and cell phenotype:evidence for the independence of cell invasion on the motile capabilities[J]. Human Mol Genet, 2003, 12 (22):3007-3016.
[13]Laco J, Ryska A, Cáp J, et al. Expression of galectin-3, cytokeratin 19, neural cell adhesion molecule and E-cadhedrin in certain variants of papillary thyroid carcinoma[J]. Cesk Patol, 2008,44(4):103-107.
[14]Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis[J]. Cell,2004,117(7):927-939.
[15]Peifer M, Polakis P. Wnt signaling in oncogenesis and enbryogenesis-a look outside the nucleus[J]. Science,2000,287(5458):1606-1609.
[16]Fujimori M, Ikeda S, Shimizu Y, et al. Accumulation of beta-catenin protein and mutationa in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor[J]. Cancer Res,2001,61(18):6656-6659.
[17]Verma UN, Surabbi RM, Schmaltieg A, et al. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells[J]. Clin Cancer Res,2003,9(4):1291-1300.
[18]Zhang GJ.Cyclin D1 and β-catenin protein expression in thyroid carcinoma tissue[J]. Chinese Journal of Control of Endemic Diseases,2014,29(3):174-176 . (in Chinese)
张贵军. Cyclin D1 和β-catenin 在甲状腺癌组织中的蛋白表达[J].中国地方病防治杂志,2014,29(3):174-176.
[19]Kaur J,Sawhney U,Datta Gupta S,et al. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer:potential link with ALCAM expression[J].PLoS One,2013,8(6): e67361. |